Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Spatial distribution of Plasmodium vivax Duffy Binding Protein copy number variation and Duffy genotype, and their association with parasitemia in Ethiopia

View through CrossRef
Background Duffy Binding Protein (PvDBP) binding to the Duffy antigen receptor for chemokine (DARC) is essential for Plasmodium vivax invasion of human reticulocytes. PvDBP copy number variation (CNV) might increase parasite invasion and thus parasitemia. We examined the spatial distribution of PvDBP CNVs and DARC genotypes and their association with parasitemia in P. vivax endemic settings in Ethiopia. Methodology/Principal findings P. vivax isolates (n = 435) collected from five P. vivax endemic settings in Ethiopia were genotyped by amplifying the GATA1 transcription factor-binding site of the Duffy blood group and the CNV of PvDBP was quantified. Parasitemia was determined using 18S-based qPCR. The majority of participants were Duffy positive (96.8%, 421/435). Of the few Duffy negative individuals, most (n = 8) were detected from one site (Gondar). Multiple copies of PvDBP were detected in 83% (363/435) isolates with significant differences between sites (range 60%-94%). Both heterozygous (p = 0.005) and homozygous (p = 0.006) patients were more likely to have been infected by parasites with multiple PvDBP copies than Duffy negatives. Parasitemia was higher among the Duffy positives (median 17,218 parasites/µL; interquartile range [IQR] 2,895–104,489) than Duffy negatives (170; 78–24,132, p = 0.004) as well as in infections with 2 to 3 PvDBP copies (20,468; 3,649–110,632, p = 0.001) and more than 3 PvDBP copies (17,139; 2,831–95,946, p = 0.004) than single copy (5,673; 249–76,605). Conclusions/Significance A high proportion of P. vivax infection was observed in Duffy positives in this study, yet few Duffy negatives were found infected with P. vivax. The significant prevalence of multi-copy PvDBP observed among Ethiopian P. vivax isolates explains the high prevalence and parasitemia observed in clinical cases. This suggests that vivax malaria is a public health concern in the country where the Duffy positive population predominates. Investigating the relative contribution to the maintenance of the infectious reservoir of infections with different genotyping backgrounds (both host and parasite) might be required.
Title: Spatial distribution of Plasmodium vivax Duffy Binding Protein copy number variation and Duffy genotype, and their association with parasitemia in Ethiopia
Description:
Background Duffy Binding Protein (PvDBP) binding to the Duffy antigen receptor for chemokine (DARC) is essential for Plasmodium vivax invasion of human reticulocytes.
PvDBP copy number variation (CNV) might increase parasite invasion and thus parasitemia.
We examined the spatial distribution of PvDBP CNVs and DARC genotypes and their association with parasitemia in P.
vivax endemic settings in Ethiopia.
Methodology/Principal findings P.
vivax isolates (n = 435) collected from five P.
vivax endemic settings in Ethiopia were genotyped by amplifying the GATA1 transcription factor-binding site of the Duffy blood group and the CNV of PvDBP was quantified.
Parasitemia was determined using 18S-based qPCR.
The majority of participants were Duffy positive (96.
8%, 421/435).
Of the few Duffy negative individuals, most (n = 8) were detected from one site (Gondar).
Multiple copies of PvDBP were detected in 83% (363/435) isolates with significant differences between sites (range 60%-94%).
Both heterozygous (p = 0.
005) and homozygous (p = 0.
006) patients were more likely to have been infected by parasites with multiple PvDBP copies than Duffy negatives.
Parasitemia was higher among the Duffy positives (median 17,218 parasites/µL; interquartile range [IQR] 2,895–104,489) than Duffy negatives (170; 78–24,132, p = 0.
004) as well as in infections with 2 to 3 PvDBP copies (20,468; 3,649–110,632, p = 0.
001) and more than 3 PvDBP copies (17,139; 2,831–95,946, p = 0.
004) than single copy (5,673; 249–76,605).
Conclusions/Significance A high proportion of P.
vivax infection was observed in Duffy positives in this study, yet few Duffy negatives were found infected with P.
vivax.
The significant prevalence of multi-copy PvDBP observed among Ethiopian P.
vivax isolates explains the high prevalence and parasitemia observed in clinical cases.
This suggests that vivax malaria is a public health concern in the country where the Duffy positive population predominates.
Investigating the relative contribution to the maintenance of the infectious reservoir of infections with different genotyping backgrounds (both host and parasite) might be required.

Related Results

PLASMODIUM VIVAX INFECTIONS IN DUFFY-NEGATIVE INDIVIDUALS: A PARADIGM SHIFT IN INDIAN MALARIA EPIDEMIOLOGY
PLASMODIUM VIVAX INFECTIONS IN DUFFY-NEGATIVE INDIVIDUALS: A PARADIGM SHIFT IN INDIAN MALARIA EPIDEMIOLOGY
Aim: To investigate the occurrence of Plasmodium vivax infections in Duffy-negative individuals, challenging the long-held belief that P. vivax requires the Duffy antigen receptor...
Development of a Novel Cytochrome b Real-Time PCR Assay for Identification of Plasmodium malariae
Development of a Novel Cytochrome b Real-Time PCR Assay for Identification of Plasmodium malariae
This article aims to establish a novel cytochrome b real-time PCR assay using Taqman probe for identification of P. malariae and its discrimination from other Plasmodium human infe...
Prevalence of Plasmodium Species among Humans and Monkeys at Mole National Park in Northern Ghana
Prevalence of Plasmodium Species among Humans and Monkeys at Mole National Park in Northern Ghana
Malaria is one of the most severe public health problems in Ghana. In developing countries such as Ghana, with high of prevalence of malaria, the procedures for diagnoses and detec...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Targeting the Duffy binding protein to develop a blood stage vaccine for Plasmodium vivax malaria
Targeting the Duffy binding protein to develop a blood stage vaccine for Plasmodium vivax malaria
Cibler la Duffy binding protein pour développer un vaccin au stade sanguin contre le paludisme de Plasmodium vivax Plasmodium vivax est le parasite du paludisme pré...

Back to Top